Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| PEP-Therapy | 2021 | Series A | $1.9M | Évry |
| Clim8 | 2021 | Convertible Note | $3.9M | Écully |
| Cytoki Pharma | 2021 | Series A | $45.0M | Værløse |
| wealthpilot | 2021 | Series Unknown | $9.7M | Munich |
| Dermala | 2020 | Series A | $4.5M | San Diego |
| Federation Bio | 2020 | Series A | $50.0M | South San Francisco |
| LARQ | 2020 | Series A | $10.7M | Foster City |
| MOVE ‘N SEE | 2020 | Series Unknown | $4.5M | Plouzané |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 101 | PEP-Therapy | Series A | $1.9M | Évry, France |
| 102 | Clim8 | Convertible Note | $3.9M | Écully, France |
| 103 | Cytoki Pharma | Series A | $45.0M | Værløse, Denmark |
| 104 | wealthpilot | Series Unknown | $9.7M | Munich, Germany |
| 105 | Dermala | Series A | $4.5M | San Diego, United States |
| 106 | Federation Bio | Series A | $50.0M | South San Francisco, United States |
| 107 | LARQ | Series A | $10.7M | Foster City, United States |
| 108 | MOVE ‘N SEE | Series Unknown | $4.5M | Plouzané, France |
| 109 | TIBOT Technologies | Seed | $3.3M | Bretagne, France |
| 110 | Keen Eye Technologies | Series A | $6.7M | Paris, France |
Innovative peptides as targeted therapies for oncology
Clim8 is poised to stand at the forefront of intelligent thermal clothing.
Cytoki Pharma is a biotechnology company that specializes in developing novel medicines for diseases.
wealthpilot enables professional advisors to deliver a data-driven and truly personal wealth management.
DERMALA develops personalized, clinically validated, patented treatments for chronic skin conditions including acne & eczema.
Federation Bio is a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role.
LARQ helps people access pristine drinking water easily and sustainably.
Your Personal Robot Cameraman for INDOOR and OUTDOOR shooting.
TIBOT Technologies is a pioneer in poultry robotics.
Keen Eye Technologies is a health tech company.
MilliDrop works on a new generation of in-vitro diagnostics instruments called MilliDrop DIV.
MDoloris Medical Systems commercializes, manufactures, designs and develops all types of medical equipment intended to soothe, lessen.
Indexima is creating momentum for Data Driven companies aiming for Zero Time to Data.
A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium.
Future of food safety and traceability - Inspecto developed groundbreaking technology for the detection of contaminants in food in the field
Il Etait Un Fruit is offering delicious dehydrated fruit petals.
To provide responsive technology for analog IP.
Machtfit is a health wellness and fitness company, provides corporate health solutions for companies and their employees.
TargEDys develops functional food, medical food and medical products to harness the microbiota’s ability to regulate appetite.
Chronotruck is a smartphone application that allows customers to find free carriers, geolocated around them.
Yelloan offers an innovative service of participatory guarantee.
A Paris, France-based company that develops and markets technologies for high-pressure vitrification
payleven enables small and medium sized businesses to accept card payments via smartphone or tablet.
MinuteBuzz is an entertainment network.
Myobis is a a german software specialist for the tourism and events sector.
Seventure Partners has invested in 125 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Seventure Partners's top investment sectors include Biotechnology, Health Care, Medical Device, Software, Life Science. The firm invests across 55 different industry categories.
Among tracked funding rounds, Federation Bio received $50.0M in a Series A round. Seventure Partners's total known invested capital is $1.5B.
Seventure Partners's average investment size is $18.9M across its portfolio of 125 companies.
Recent Seventure Partners portfolio additions include PEP-Therapy, Clim8, Cytoki Pharma, wealthpilot, Dermala. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors